Botox maker Allergan to acquire Australian bitoech firm Elastagen for $95m
Summary
Allergan, a global pharmaceutical company and also the maker of Botox, is acquiring Australia’s biotech firm Elastagen Pty Ltd for an upfront payment of $95 million, Elastagen announced on Wednesday.
Classifications
industries
Fintech & Banking
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected